ATF4 Protects the Heart From Failure by Antagonizing Oxidative Stress
暂无分享,去创建一个
Xiang Luo | B. Rothermel | T. Gillette | Joseph A. Hill | P. Scherer | P. Lorenzi | L. Tan | A. Ferdous | Zhao V. Wang | Qinfeng Li | Guangyu Zhang | Erica Niewold | Xiaoding Wang | Chao Li | S. Dasgupta | Christopher M. Adams | Erica L Niewold
[1] Rizwan Kalani,et al. Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association , 2022, Circulation.
[2] J. Molkentin,et al. Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy , 2021, Nature communications.
[3] M. V. Vander Heiden,et al. PKM1 Exerts Critical Roles in Cardiac Remodeling Under Pressure Overload in the Heart , 2021, Circulation.
[4] J. Xia,et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights , 2021, Nucleic Acids Res..
[5] R. Deberardinis,et al. Mitochondrial NADP+ is essential for proline biosynthesis during cell growth , 2021, Nature Metabolism.
[6] K. De Keersmaecker,et al. The ins and outs of serine and glycine metabolism in cancer , 2021, Nature Metabolism.
[7] K. Parnell,et al. The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. , 2020, Cell metabolism.
[8] M. Crespo-Leiro,et al. Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy , 2020, Nature Metabolism.
[9] O. Ilkayeva,et al. Nutritional modulation of heart failure in mitochondrial pyruvate carrier–deficient mice , 2020, Nature Metabolism.
[10] D. Xie,et al. NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications , 2020, Signal Transduction and Targeted Therapy.
[11] J. Asara,et al. The mTORC1-mediated activation of ATF4 promotes protein and glutathione synthesis downstream of growth signals , 2020, bioRxiv.
[12] Paul V. Taufalele,et al. Mitochondrial Pyruvate Carriers are Required for Myocardial Stress Adaptation , 2020, Nature Metabolism.
[13] M. Packer. Uric Acid Is a Biomarker of Oxidative Stress in the Failing Heart: Lessons Learned from Trials With Allopurinol and SGLT2 Inhibitors. , 2020, Journal of cardiac failure.
[14] Herman I. May,et al. Chronic activation of hexosamine biosynthesis in the heart triggers pathological cardiac remodeling , 2020, Nature Communications.
[15] G. Hart,et al. Excessive O - GlcNAcylation causes heart failure and sudden death , 2020, bioRxiv.
[16] Herman I. May,et al. Spliced X-Box Binding Protein 1 Stimulates Adaptive Growth Through Activation of mTOR. , 2019, Circulation.
[17] Z. Ignatova,et al. ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumor progression , 2019, Nature Cell Biology.
[18] J. Weinstein,et al. ElemCor: accurate data analysis and enrichment calculation for high-resolution LC-MS stable isotope labeling experiments , 2019, BMC Bioinformatics.
[19] Xiang Luo,et al. GRP78 (Glucose-Regulated Protein of 78 kDa) Promotes Cardiomyocyte Growth Through Activation of GATA4 (GATA-Binding Protein 4) , 2019, Hypertension.
[20] B. Hill,et al. Metabolic Coordination of Physiological and Pathological Cardiac Remodeling , 2018, Circulation research.
[21] J. Loscalzo,et al. NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism. , 2018, Antioxidants & redox signaling.
[22] B. Viollet,et al. AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation , 2018, Nature Communications.
[23] O. Gorbatyuk,et al. Neurodegeneration: Keeping ATF4 on a Tight Leash , 2017, Front. Cell. Neurosci..
[24] Herman I. May,et al. Temporal dynamics of cardiac hypertrophic growth in response to pressure overload. , 2017, American journal of physiology. Heart and circulatory physiology.
[25] Inge M. N. Wortel,et al. Surviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and Malignant Cells , 2017, Trends in Endocrinology & Metabolism.
[26] E. Pearce,et al. Ancillary Activity: Beyond Core Metabolism in Immune Cells. , 2017, Cell metabolism.
[27] Joshua D Rabinowitz,et al. One-Carbon Metabolism in Health and Disease. , 2017, Cell metabolism.
[28] Gianluigi Savarese,et al. Global Public Health Burden of Heart Failure. , 2016, Cardiac failure review.
[29] J. Rabinowitz,et al. Malic enzyme tracers reveal hypoxia-induced switch in adipocyte NADPH pathway usage. , 2016, Nature chemical biology.
[30] Q. Wang,et al. Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer , 2016, Cell Death and Disease.
[31] J. Asara,et al. mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle , 2016, Science.
[32] G. Figtree,et al. Redox biomarkers in cardiovascular medicine. , 2015, European heart journal.
[33] N. Hay,et al. The pentose phosphate pathway and cancer. , 2014, Trends in biochemical sciences.
[34] T. Shlomi,et al. Quantitative flux analysis reveals folate-dependent NADPH production , 2014, Nature.
[35] P. Storz. Oxidative Stress in Cancer , 2013 .
[36] N. Hay,et al. Molecular Pathways: Reactive Oxygen Species Homeostasis in Cancer Cells and Implications for Cancer Therapy , 2013, Clinical Cancer Research.
[37] D. Kass,et al. Nitric oxide synthases in heart failure. , 2013, Antioxidants & redox signaling.
[38] I. Mills,et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. , 2012, The Journal of clinical investigation.
[39] Steven D. Kunkel,et al. Stress-induced Skeletal Muscle Gadd45a Expression Reprograms Myonuclei and Causes Muscle Atrophy* , 2012, The Journal of Biological Chemistry.
[40] P. Ray,et al. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. , 2012, Cellular signalling.
[41] C. Palmeira,et al. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. , 2012, Free radical biology & medicine.
[42] Hongqiao Zhang,et al. Glutathione: overview of its protective roles, measurement, and biosynthesis. , 2009, Molecular aspects of medicine.
[43] W. Ying. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. , 2008, Antioxidants & redox signaling.
[44] D. Harrison,et al. Molecular Mechanisms of Angiotensin II–Mediated Mitochondrial Dysfunction: Linking Mitochondrial Oxidative Damage and Vascular Endothelial Dysfunction , 2007, Circulation research.
[45] Hiroyuki Tsutsui,et al. [Oxidative stress and heart failure]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.
[46] A. Shah,et al. Oxidative stress in heart failure. More than just damage. , 2003, European heart journal.
[47] L. Dell’Italia,et al. Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats. , 2003, American journal of physiology. Heart and circulatory physiology.
[48] A. Shah,et al. Increased myocardial NADPH oxidase activity in human heart failure. , 2003, Journal of the American College of Cardiology.
[49] D. Kass,et al. Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy , 2001, Circulation.
[50] J. Ross,et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy , 1991, Proceedings of the National Academy of Sciences of the United States of America.